| John Garrett Llewelyn, MD | |
|
1000 Houghton Ave, Saginaw, MI 48602-5303 | |
| (989) 746-7500 | |
| Not Available |
| Full Name | John Garrett Llewelyn |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 8 Years |
| Location | 1000 Houghton Ave, Saginaw, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326497066 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 4301506644 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Covenant Medical Center | Saginaw, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Valley Ob Gyn Clinic Pc | 6002803871 | 6 |
News Archive
The Antibiotic Resistance Threats Report released by the U.S. Centers for Disease Prevention and Control today shows that while recent federal investments to combat antibiotic resistance have had meaningful impacts, the continued spread of infections that are not effectively treated by existing medicines pose deadly threats to patients and public health.
Aprotinin, a drug used for limiting blood loss in patients undergoing cardiac surgery, is associated with an increased risk of death during five years following the surgery, according to a new study in the February 7 issue of JAMA: The Journal of the American Medical Association.
NeoRx Corporation today announced that it has acquired from AnorMED Inc. the worldwide exclusive rights, excluding Japan, to develop, manufacture and commercialize AMD473, a platinum-based anti-cancer agent. AMD473 has been administered to more than 500 cancer patients in phase I and phase II clinical trials, demonstrating anti-cancer activity in a wide range of tumors and a manageable safety profile. NeoRx expects to initiate clinical studies of AMD473 in one or more cancer indications in the second half of this year.
Using one standardized screening tool to identify adults who may have malnutrition (undernutrition) increases the likelihood of an accurate diagnosis and timely treatment, according to a position paper from the Academy of Nutrition and Dietetics.
› Verified 7 days ago
| Entity Name | Saginaw Cooperative Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346344991 PECOS PAC ID: 3971400318 Enrollment ID: O20031215000723 |
News Archive
The Antibiotic Resistance Threats Report released by the U.S. Centers for Disease Prevention and Control today shows that while recent federal investments to combat antibiotic resistance have had meaningful impacts, the continued spread of infections that are not effectively treated by existing medicines pose deadly threats to patients and public health.
Aprotinin, a drug used for limiting blood loss in patients undergoing cardiac surgery, is associated with an increased risk of death during five years following the surgery, according to a new study in the February 7 issue of JAMA: The Journal of the American Medical Association.
NeoRx Corporation today announced that it has acquired from AnorMED Inc. the worldwide exclusive rights, excluding Japan, to develop, manufacture and commercialize AMD473, a platinum-based anti-cancer agent. AMD473 has been administered to more than 500 cancer patients in phase I and phase II clinical trials, demonstrating anti-cancer activity in a wide range of tumors and a manageable safety profile. NeoRx expects to initiate clinical studies of AMD473 in one or more cancer indications in the second half of this year.
Using one standardized screening tool to identify adults who may have malnutrition (undernutrition) increases the likelihood of an accurate diagnosis and timely treatment, according to a position paper from the Academy of Nutrition and Dietetics.
› Verified 7 days ago
| Entity Name | Valley Ob Gyn Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891803904 PECOS PAC ID: 6002803871 Enrollment ID: O20040426001423 |
News Archive
The Antibiotic Resistance Threats Report released by the U.S. Centers for Disease Prevention and Control today shows that while recent federal investments to combat antibiotic resistance have had meaningful impacts, the continued spread of infections that are not effectively treated by existing medicines pose deadly threats to patients and public health.
Aprotinin, a drug used for limiting blood loss in patients undergoing cardiac surgery, is associated with an increased risk of death during five years following the surgery, according to a new study in the February 7 issue of JAMA: The Journal of the American Medical Association.
NeoRx Corporation today announced that it has acquired from AnorMED Inc. the worldwide exclusive rights, excluding Japan, to develop, manufacture and commercialize AMD473, a platinum-based anti-cancer agent. AMD473 has been administered to more than 500 cancer patients in phase I and phase II clinical trials, demonstrating anti-cancer activity in a wide range of tumors and a manageable safety profile. NeoRx expects to initiate clinical studies of AMD473 in one or more cancer indications in the second half of this year.
Using one standardized screening tool to identify adults who may have malnutrition (undernutrition) increases the likelihood of an accurate diagnosis and timely treatment, according to a position paper from the Academy of Nutrition and Dietetics.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Garrett Llewelyn, MD 1000 Houghton Ave, Saginaw, MI 48602-5303 Ph: (899) 746-7500 | John Garrett Llewelyn, MD 1000 Houghton Ave, Saginaw, MI 48602-5303 Ph: (989) 746-7500 |
News Archive
The Antibiotic Resistance Threats Report released by the U.S. Centers for Disease Prevention and Control today shows that while recent federal investments to combat antibiotic resistance have had meaningful impacts, the continued spread of infections that are not effectively treated by existing medicines pose deadly threats to patients and public health.
Aprotinin, a drug used for limiting blood loss in patients undergoing cardiac surgery, is associated with an increased risk of death during five years following the surgery, according to a new study in the February 7 issue of JAMA: The Journal of the American Medical Association.
NeoRx Corporation today announced that it has acquired from AnorMED Inc. the worldwide exclusive rights, excluding Japan, to develop, manufacture and commercialize AMD473, a platinum-based anti-cancer agent. AMD473 has been administered to more than 500 cancer patients in phase I and phase II clinical trials, demonstrating anti-cancer activity in a wide range of tumors and a manageable safety profile. NeoRx expects to initiate clinical studies of AMD473 in one or more cancer indications in the second half of this year.
Using one standardized screening tool to identify adults who may have malnutrition (undernutrition) increases the likelihood of an accurate diagnosis and timely treatment, according to a position paper from the Academy of Nutrition and Dietetics.
› Verified 7 days ago
Mrs. Veronika Kinaschuk, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-746-7500 Fax: 989-746-7658 | |
Dr. Omaima Ali A Al Sinan, M.D Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-583-6828 | |
Vickie B Mello, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-746-7500 | |
Riva Marais Macbeth Morin, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1000 Houghton Ave Ofc, Saginaw, MI 48602 Phone: 989-746-7500 Fax: 989-746-7747 | |
Dr. Brian Sinischo, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-583-6828 | |
Sarine Trochakerian, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-583-6828 | |
Dr. Jacquelyn Austin Robinson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 926 N Michigan Ave, Saginaw, MI 48602 Phone: 989-753-8453 Fax: 989-753-3519 |